Transactions
14
Insider / AMGEN INC
Santos Esteban
EVP, Operations at AMGEN INC
- Company
- AMGEN INC
- Ticker
- AMGN
- First filing on record
- March 2, 2026
- Latest trade on record
- May 7, 2026
- SEC filings
- EDGAR ↗
Santos Esteban, EVP, Operations at AMGEN INC, has disclosed 14 transactions in AMGN since March 2, 2026: 0 purchases (0 open-market buys) and 7 sales, worth about $38.7M at the reported prices. The latest was filed May 11, 2026, 4 days after the trade.
Open-market buys
0
Sales
7
Avg. disclosure lag
3.1d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Santos Esteban made no purchases and 7 sales worth $24M, plus 7 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Santos Esteban has traded 1 stock on record; the largest by dollars is AMGN.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 6 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| F | Shares withheld for tax | 5 | 7,908 | $2.8M |
| M | Option exercise or conversion | 4 | 109,584 | $9.3M |
| A | Grant or award | 3 | 31,803 | $5.9M |
| S | Open-market sale | 2 | 54,792 | $20.8M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 14 | 0 | 7 · $23.6M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | Sell F | May 7, 2026 | May 11, 2026 | 4d | 522 | $331 | $173K | Form 4 ↗ | ||
| AMGN | Other A | May 5, 2026 | May 7, 2026 | 2d | 17,814 | $330 | $5.9M | derivative | Form 4 ↗ | |
| AMGN | Sell F | May 6, 2026 | May 7, 2026 | 1d | 427 | $330 | $141K | Form 4 ↗ | ||
| AMGN | Other A | May 5, 2026 | May 7, 2026 | 2d | 2,730 | — | — | Form 4 ↗ | ||
| AMGN | Sell F | May 2, 2026 | May 5, 2026 | 3d | 641 | $330 | $211K | Form 4 ↗ | ||
| AMGN | Sell F | May 2, 2026 | May 5, 2026 | 3d | 697 | $330 | $230K | Form 4 ↗ | ||
| AMGN | Sell F | March 16, 2026 | March 18, 2026 | 2d | 5,621 | $366 | $2.1M | Form 4 ↗ | ||
| AMGN | Other A | March 3, 2026 | March 5, 2026 | 2d | 11,259 | — | — | Form 4 ↗ | ||
| AMGN | Option / conversion M | February 26, 2026 | March 2, 2026 | 4d | 24,291 | — | — | derivative | Form 4 ↗ | |
| AMGN | Option / conversion M | February 26, 2026 | March 2, 2026 | 4d | 30,501 | — | — | derivative | Form 4 ↗ | |
| AMGN | Sell S | February 26, 2026 | March 2, 2026 | 4d | 24,291 | $379 | $9.2M | Form 4 ↗ | ||
| AMGN | Option / conversion M | February 26, 2026 | March 2, 2026 | 4d | 24,291 | $177 | $4.3M | Form 4 ↗ | ||
| AMGN | Sell S | February 26, 2026 | March 2, 2026 | 4d | 30,501 | $379 | $11.6M | Form 4 ↗ | ||
| AMGN | Option / conversion M | February 26, 2026 | March 2, 2026 | 4d | 30,501 | $163 | $5.0M | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 11, 2026 | Form 4 | 0000318154-26-000092 | 1 | published | EDGAR ↗ |
| May 7, 2026 | Form 4 | 0000318154-26-000072 | 3 | published | EDGAR ↗ |
| May 5, 2026 | Form 4 | 0000318154-26-000068 | 2 | published | EDGAR ↗ |
| March 18, 2026 | Form 4 | 0000318154-26-000033 | 1 | published | EDGAR ↗ |
| March 5, 2026 | Form 4 | 0000318154-26-000022 | 1 | published | EDGAR ↗ |
| March 2, 2026 | Form 4 | 0000318154-26-000012 | 6 | published | EDGAR ↗ |
Other insiders at AMGEN INC
- Grygiel Nancy A. SVP & CCO 21 rows
- Kullman Ellen Jamison Director 16 rows
- Bradway Robert A Chairman, CEO and President 15 rows
- Khosla Rachna SVP, Business Development 14 rows
- Miller Derek SVP, Human Resources 14 rows
- Busch Matthew C. VP, Finance & CAO 11 rows
- REESE DAVID M EVP & Chief Technology Officer 10 rows
- Gordon Murdo EVP, Global Commercial Ops 9 rows
- Graham Jonathan P EVP & Gen. Counsel & Sec. 8 rows
- Griffith Peter H. EVP & CFO 8 rows
Everyone on file, with contracts and lobbying under the company's name: AMGEN INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 6 | 14 | March 2, 2026 | May 11, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.